These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7428798)

  • 1. Wide variation in serum chlorpropamide concentration in outpatients.
    Bergman U; Christenson I; Jansson B; Wiholm B-E ; Ostman
    Eur J Clin Pharmacol; 1980 Aug; 18(2):165-9. PubMed ID: 7428798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irregular drug intake and serum chlorpropaminde concentrations.
    Wilholm B-E
    Eur J Clin Pharmacol; 1980 Aug; 18(2):159-63. PubMed ID: 7428797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus.
    Melander A; Sartor G; Wåhlin E; Scherstén B; Bitzén PO
    Br Med J; 1978 Jan; 1(6106):142-4. PubMed ID: 620227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorpropamide and glibenclamide serum concentrations in hospitalized patients.
    Huupponen R; Viikari J; Saarimaa H
    Ann Clin Res; 1982 Jun; 14(3):119-22. PubMed ID: 6814340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of rifampin and chlorpropamide.
    Self TH; Morris T
    Chest; 1980 Jun; 77(6):800-1. PubMed ID: 7398394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.
    Ward EA; Lang DA; Phillips MR; Turner RC
    Diabetes Care; 1981; 4(2):293-5. PubMed ID: 6783374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between serum concentration and hypoglycemic effect of chlorpropamide in man.
    Jankowski A; Wichliński LM; Bokowski W; Romański B
    Pol J Pharmacol Pharm; 1984; 36(5):449-53. PubMed ID: 6533629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide.
    Shenfield GM; Logan A; Shirling D; Baird J
    Diabetologia; 1977 Aug; 13(4):367-71. PubMed ID: 913926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of comparative effectiveness of oral hypoglycaemic agents in single dose in diabetes mellitus.
    Ahuja MM; Kumar V
    J Indian Med Assoc; 1971 Jun; 56(12):366-70. PubMed ID: 5118286
    [No Abstract]   [Full Text] [Related]  

  • 10. [The serum chlorpropamide level after its administration to patients with diabetes mellitus].
    Masevich TsG; Safonova EN
    Ter Arkh; 1985; 57(12):26-8. PubMed ID: 4089764
    [No Abstract]   [Full Text] [Related]  

  • 11. Combinations of oral hypoglycemic drugs in obese, insulin-resistant diabetics.
    Fineberg SK
    Geriatrics; 1968 Sep; 23(9):137-46. PubMed ID: 5673663
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of long term sulfonylurea therapy on plasma insulin and fasting lipid levels.
    Podolsky S; Burney SW
    Diabete Metab; 1979 Jun; 5(2):113-7. PubMed ID: 478080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glibenclamide--a better antidiabetic agent?].
    Blohmé G
    Lakartidningen; 1972 Dec; 69(52):6147-9. PubMed ID: 4631025
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal.
    Tsalikian E; Dunphy TW; Bohannon NV; Lorenzi M; Gerich JE; Forsham PH; Kane JP; Karam JH
    Diabetes; 1977 Apr; 26(4):314-21. PubMed ID: 849812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of gas-chromatographic method for blood chlorpropamide determination and evaluation of its use for clinical and pharmacological purposes.
    Nasierowska Z; Suffczyński J; Szyszko E; Tatoń J; Koliński P; Czech A; Wojterska J
    Pol J Pharmacol Pharm; 1983; 35(5):405-15. PubMed ID: 6364074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring metabolic control in diabetic outpatients with glycosylated hemoglobin.
    Boden G; Master RW; Gordon SS; Shuman CR; Owen OE
    Ann Intern Med; 1980 Mar; 92(3):357-60. PubMed ID: 7356230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of glibenclamide & chlorpropamide in newly diagnosed maturity onset diabetics.
    Haider Z; Obaidullah S; Fayyaz-ud-Din
    J Pak Med Assoc; 1976 Feb; 26(2):23-6. PubMed ID: 817043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity-onset diabetes mellitus.
    Reaven G; Dray J
    Diabetes; 1967 Jul; 16(7):487-92. PubMed ID: 6028757
    [No Abstract]   [Full Text] [Related]  

  • 19. The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy.
    Chu PC; Conway MJ; Krouse HA; Goodner CJ
    Ann Intern Med; 1968 Apr; 68(4):757-69. PubMed ID: 4868334
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Treatment of maturity-onset diabetes.
    Clarke BF; Campbell IW
    Lancet; 1975 Mar; 1(7906):580-1. PubMed ID: 47059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.